The emphasis is on interoperability, real-time data, and AI as core enablers for smarter procurement, replenishment, and distribution across the sector.

India’s long-term goal is to transform its pharma supply chain from fragmented and reactive to predictive, connected, and intelligent, ensuring the right medicine reaches the right place at the right time with lower costs.

AI acts as a decision-support layer at scale, advising reorders, stock movements, and expiry-risk mitigation across thousands of SKUs and locations to boost availability while cutting wastage and working capital.

DocPharma is highlighted as an example of improved availability and reduced working capital and wastage through unified data and AI-enabled processes.

The article notes fragmented data across ERP systems and manual processes that cause stock-outs and higher working capital, arguing for a real-time, unified view of inventory and demand via AI/ML.

A real-time technology layer is essential, requiring an API-first, cloud-native architecture with scalable infrastructure and event-driven design to reflect inventory and order changes instantly.

AI/ML workflows forecast demand at SKU and location levels by combining historical sales, seasonality, disease trends, prescription patterns, and live inventory data to enable proactive replenishment and stock reallocation.

The modernization effort envisions a unified, predictive digital ecosystem based on API-first, cloud-native technology that connects manufacturers, distributors, pharmacies, and logistics.